422 related articles for article (PubMed ID: 17075972)
21. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
23. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R
Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442
[TBL] [Abstract][Full Text] [Related]
24. Management of gastroesophageal junction tumors.
Fox MP; van Berkel V
Surg Clin North Am; 2012 Oct; 92(5):1199-212. PubMed ID: 23026278
[TBL] [Abstract][Full Text] [Related]
25. [Current status and challenges of clinical trial on adenocarcinoma of esophagogastric junction].
Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):112-118. PubMed ID: 30799533
[TBL] [Abstract][Full Text] [Related]
26. [Optimal surgical approach for esophagogastric junction carcinoma].
Yamashita H; Seto Y
Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):40-4. PubMed ID: 25842812
[TBL] [Abstract][Full Text] [Related]
27. Clinical application and observation of modified Ivor-Lewis surgery in Siewert type II adenocarcinoma of the Esophagogastric junction.
Yin Q; Wang W; Liu H; Yang G; Zhou S; Liu L
J Cardiothorac Surg; 2019 Nov; 14(1):207. PubMed ID: 31775820
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction].
Yan Q; Lyu ZJ; Zheng JB; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000
[TBL] [Abstract][Full Text] [Related]
29. [Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction].
Schröder W; Lambertz R; van Hillegesberger R; Bruns C
Chirurg; 2017 Dec; 88(12):1010-1016. PubMed ID: 29098306
[TBL] [Abstract][Full Text] [Related]
30. Ongoing Controversies in Esophageal Cancer II: Gastrectomy versus Esophagectomy for Siewert Type II Esophageal Adenocarcinoma.
Devaud N; Carroll P
Thorac Surg Clin; 2022 Nov; 32(4):553-563. PubMed ID: 36266040
[TBL] [Abstract][Full Text] [Related]
31. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
Zhang XH; Wang QZ
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
[No Abstract] [Full Text] [Related]
32. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
Blank S; Schmidt T; Heger P; Strowitzki MJ; Sisic L; Heger U; Nienhueser H; Haag GM; Bruckner T; Mihaljevic AL; Ott K; Büchler MW; Ulrich A
Gastric Cancer; 2018 Mar; 21(2):303-314. PubMed ID: 28685209
[TBL] [Abstract][Full Text] [Related]
33. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
[TBL] [Abstract][Full Text] [Related]
34. Technical aspects and results of the transhiatal resection in adenocarcinomas of the gastroesophageal junction.
Ulrich B; Zahedi A
Dis Esophagus; 2001; 14(2):115-9. PubMed ID: 11553220
[TBL] [Abstract][Full Text] [Related]
35. [The choice of surgical therapy in adenocarcinoma of the cardia].
Solerio D; Camandona M; Gasparri G; Casalegno PA; Raggio E; Dei Poli M
Minerva Chir; 2005 Feb; 60(1):17-22. PubMed ID: 15902049
[TBL] [Abstract][Full Text] [Related]
36. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers.
Hölscher AH; Law S
Gastric Cancer; 2020 Jan; 23(1):3-9. PubMed ID: 31691875
[TBL] [Abstract][Full Text] [Related]
37. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
38. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
[TBL] [Abstract][Full Text] [Related]
39. Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.
Koëter M; Parry K; Verhoeven RH; Luyer MD; Ruurda JP; van Hillegersberg R; Lemmens VE; Nieuwenhuijzen GA
Ann Surg Oncol; 2016 May; 23(5):1632-8. PubMed ID: 26727917
[TBL] [Abstract][Full Text] [Related]
40. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.
Hölscher AH; Bollschweiler E; Fetzner UK; Babic B
Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
